WUXIHIGH Trademark

Trademark Overview


On Tuesday, May 31, 2022, a trademark application was filed for WUXIHIGH with the United States Patent and Trademark Office. The USPTO has given the WUXIHIGH trademark a serial number of 97436004. The federal status of this trademark filing is REGISTERED as of Tuesday, February 6, 2024. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The WUXIHIGH trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals by pharmaceutical compounders; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Custom manufacture of nutraceuticals by pharmaceutical compounders; Custom manufacture of vitamins for humans

Product development for others; pharmaceutical drug developments services; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies
wuxihigh

General Information


Serial Number97436004
Word MarkWUXIHIGH
Filing DateTuesday, May 31, 2022
Status700 - REGISTERED
Status DateTuesday, February 6, 2024
Registration Number7300666
Registration DateTuesday, February 6, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals by pharmaceutical compounders; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Custom manufacture of nutraceuticals by pharmaceutical compounders; Custom manufacture of vitamins for humans
Goods and ServicesProduct development for others; pharmaceutical drug developments services; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, October 31, 2022
Primary Code040
First Use Anywhere DateFriday, March 31, 2023
First Use In Commerce DateFriday, March 31, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 7, 2022
Primary Code042
First Use Anywhere DateFriday, March 31, 2023
First Use In Commerce DateFriday, March 31, 2023

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 6, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, December 30, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 29, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, July 31, 2023USE AMENDMENT FILED
Thursday, August 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 31, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 31, 2022EXAMINER'S AMENDMENT ENTERED
Monday, October 31, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 31, 2022EXAMINERS AMENDMENT E-MAILED
Monday, October 31, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 26, 2022ASSIGNED TO EXAMINER
Tuesday, June 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 3, 2022NEW APPLICATION ENTERED